Last Price$2.47NASDAQ Previous Close - Last Trade as of 3:59PM ET 8/12/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$2.30 (23)
Ask (Size)$2.47 (13)
Day Low / HighN/A - N/A
Volume30.2 K

View Pharmaceuticals: Major IndustryPeer Comparison as of 08/12/2022


ARCA Biopharma Inc ( NASDAQ )

Price: $2.47
Change: +0.07 (2.92%)
Volume: 30.2 K
3:59PM ET 8/12/2022

Cellectar Biosciences Inc ( NASDAQ )

Price: $5.88
Change: +0.03 (0.51%)
Volume: 40.5 K
4:00PM ET 8/12/2022

Cumberland Pharmaceuticals Inc ( NASDAQ )

Price: $2.45
Change: +0.01 (0.41%)
Volume: 6.0 K
4:00PM ET 8/12/2022

Applied Therapeutics Inc ( NASDAQ )

Price: $1.34
Change: +0.01 (0.75%)
Volume: 262.2 K
4:00PM ET 8/12/2022

NeuBase Therapeutics Inc ( NASDAQ )

Price: $1.14
Change: 0.00 (0.00%)
Volume: 53.7 K
3:57PM ET 8/12/2022

Read more news Recent News

-- Earnings Flash (ABIO) ARCA BIOPHARMA Posts Q2 Loss $-0.22
4:19PM ET 8/02/2022 MT Newswires


-- Earnings Flash (ABIO) ARCA BIOPHARMA Reports Q1 Loss $-0.23
4:18PM ET 5/02/2022 MT Newswires


Arca Biopharma Board to Weigh Strategic Options for Company -- Shares Rise After-Hours
4:57PM ET 4/18/2022 MT Newswires

Arca Biopharma (ABIO) said Monday its board formed a special committee of directors to study potential strategic options to maximize stockholder value. ...

Correction: Sector Update: Health Care Stocks Finishing Near Friday Session Highs
10:51AM ET 4/04/2022 MT Newswires

(Corrects to show correct name of Sage's drug candidate in third paragraph.) Health care stocks added to their midday gains this afternoon, with the NYSE...

View all Commentary and Analysis

ARCA biopharma: Activist's Pressure Could Make This Into A Liquidation Play
11:50AM ET 5/03/2022 Seeking Alpha

IPO Update: Nuvo Group Seeks $10 Million IPO
4:00PM ET 12/13/2021 Seeking Alpha

Nuvo Group Begins U.S. IPO Effort
2:06PM ET 11/30/2021 Seeking Alpha

U.S. IPO Weekly Recap: The Shortened Holiday Week Brings Just 1 IPO
10:43PM ET 11/27/2021 Seeking Alpha

Company Profile

Business DescriptionARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO. View company web site for more details
Address10170 Church Ranch Way
Westminster, Colorado 80021
Number of Employees15
Recent SEC Filing08/02/202210-Q
President, Chief Executive Officer & DirectorMichael R. Bristow
Chief Operating OfficerThomas A. Keuer
Chief Financial OfficerC. Jeffrey Dekker
Chief Medical OfficerDebra Marshall

Company Highlights

Price Open$2.40
Previous Close$2.40
52 Week Range$1.71 - 3.17
Market Capitalization$35.6 M
Shares Outstanding14.4 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement11/01/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.13
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity-33.52%

Analyst Ratings as of 11/11/2019

Consensus RecommendationConsensus Icon
Powered by Factset